Pharmabiz56m
Anticipating notification, TN IPGA starts training programme for drug inspector and medical devices officer exams
Anticipating notification, TN IPGA starts training programme for drug inspector and medical devices officer exams: Peethaambaran Kunnathoor, Chennai Wednesday, October 23, 2024, 0 ...
Pharmabiz56m
India and Germany to advance translational research in neurosciences with focus on pain management
India and Germany to advance translational research in neurosciences with focus on pain management: Nandita Vijayasimha, Bengaluru Wednesday, October 23, 2024, 08:00 Hrs [IST] Ind ...
Pharmabiz56m
DTAB recommends amendment of Rule 64 related to qualification of competent person for wholesale license
DTAB recommends amendment of Rule 64 related to qualification of competent person for wholesale license: Gireesh Babu, New Delhi Wednesday, October 23, 2024, 08:00 Hrs [IST] The D ...
Pharmabiz56m
PCI offers continuing education and skill development programmes to pharmacists
The Pharmacy Council of India (PCI) has informed all State Pharmacy Councils that the council has initiated continuing education programmes and skill development programmes to improve the skill sets ...
Pharmabiz56m
Modern HR technology reshaping workforce management for healthcare providers: Srinivas Bhararthy
Modern HR technology reshaping workforce management for healthcare providers: Srinivas Bhararthy: Shardul Nautiyal, Mumbai Wednesday, October 23, 2024, 08:00 Hrs [IST] The healthc ...
Pharmabiz56m
A RARE COMMENT ON RARE DISEASES
Justice D.Y. Chandrachud has stressed on intersection of law, ethics and medical innovation in gene therapy for treatment of rare diseases. Speaking after inaugurating a conference on ‘Gene Therapy ...
Pharmabiz18h
Lupin appoints Claus Jepsen as president, global specialty
Global pharma major Lupin Limited (Lupin) announced the appointment of Claus Jepsen as president, global specialty. He brings ...
Pharmabiz16h
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat: Taipei, Taiwan Tuesday, October 22, 202 ...
Pharmabiz18h
Sarvam gears up to make healthcare and financial assistance easier and more accessible for workers with a community for D2C engagement
Sarvam gears up to make healthcare and financial assistance easier and more accessible for workers with a community for D2C engagement: Our Bureau, Mumbai Tuesday, October 22, 202 ...
Pharmabiz15h
Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV-01
Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV-01: Rome, Italy Tuesday, October 22, 2024, 17:00 Hr ...
Pharmabiz19h
Relief Therapeutics to receive European patent covering RLF-TD011 for epidermolysis bullosa wound treatment
Relief Therapeutics to receive European patent covering RLF-TD011 for epidermolysis bullosa wound treatment: Geneva Tuesday, October 22, 2024, 13:00 Hrs [IST] Relief Therapeutics ...
Pharmabiz20h
Oculis Holding accelerates enrollment in both DIAMOND phase 3 trials of OCS-01 in diabetic macular edema
Oculis Holding accelerates enrollment in both DIAMOND phase 3 trials of OCS-01 in diabetic macular edema: Zug, Switzerland Tuesday, October 22, 2024, 12:00 Hrs [IST] Oculis Holdin ...